Daptomycin Cum Cas 103060-53-3 99% Puritas
Datomicin novum cyclicum lipopeptide antibioticum exstructum e iusculo Streptomycis e fermentatione extractum. Praeter bacteria gram-positiva ad rem maxime pertinentes amet, magis interest quod vim habet in vitro contra modos solitarios qui resistentiam methicillino, vancomycin et linezolidine ostenderunt, Haec proprietas maximam habet momentum clinicum ad criticos aegros infectos.
Product nomen: | Daptomycin | Batch No. | JL20220811 |
Cas | 103060-53-3 | MF Date | Aug |
stipare | 1KG/BAC | Analysis Date | Aug |
quantitas | 100KGS | Exitus Date | Aug |
ITEM | STANDARD | RESULT | |
Aspectus | Lumen flavo ad flavo pulveris | Conformare | |
Odor | Odorless | Conformare | |
Assay | ≥95.0% | 97.9% | |
Imprimis opticalrotationis | +15.5~+20.5 | +16.8 | |
Claritas ofsolution | Declaratur | Declaratur | |
PH | 3.0~4.5 | 3.2 | |
Reliqua ignitio | ≤0.2% | 0.1% | |
Aquae | ≤5.0% | 2.4% | |
Lactone hydrolyzate | ≤0.80% | 0.08% | |
β-isomer | ≤1.5% | 0.1% | |
RS-5/6 | ≤0.80% | 0.06% | |
RS-7 | ≤0.80% | Non detectum | |
RS-7a/7b | ≤0.20% | 0.07% | |
Anhydrodaptomycin | ≤2.0% | 0.8% | |
Alia singula | ≤0.15% | Non detectum | |
Summa immunditiae | ≤5.0% | 1.1% | |
Ethyl alcohol | ≤0.5% | 0.0% | |
Acidum aceticum | ≤0.5% | Non detectum | |
Bacteria endotoxin(EU/mg) | ≤0.28 | <0.28 | |
Aerobic bacteria(cfu/g) | ≤1000 | <10 | |
Fingunt & yeast(cfu/g) | ≤100 | <10 | |
E.coil | Non detectum | Non detectum | |
conclusio | secundum quid |
Medium medici ad curationem infectiosarum structurarum concurrentium cutem et cutem ex modis quibusdam gram-positivis et sensitivis causatis.
1kgs pera vel exigentia clientium. Abstine eam a luce ad temperiem infra 25℃.
Daptomycin Cum Cas 103060-53-3